세계의 자가 수혈 기기 시장 규모, 점유율 및 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Autotransfusion Devices Market Size, Share & Trends Analysis Report By Type (Autotransfusion Systems, Consumables& Accessories), By Application, By End Use (Hospitals & Clinics), By Region And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

자가 수혈 기기 시장 동향

자동 수혈 장비 세계 시장 규모는 2023년 4억 8,620만 달러로 추정되며, 2024-2030년간 연평균 6.3% 성장할 것으로 예상됩니다. 이 성장의 주요 요인은 생활습관 및 만성질환의 유병률 증가로 인한 수술 건수 증가로, 2024년 6월에 발표된 ISAPS의 세계 조사 2023 보고서에 따르면 2022년에 비해 수술 건수가 5.5%의 큰 폭으로 증가했다고 합니다. 성형외과 의사들은 전 세계적으로 1,580만 건 이상의 수술을 진행했으며, 이는 미용 수술에 대한 수요가 증가하고 있음을 보여줍니다.

또한 헌혈 및 동종 혈액의 부족은 환자의 혈액을 정화하는 데 매우 유용하기 때문에 자가 수혈 시스템의 광범위한 사용으로 인해 시장 성장을 가속하고 있습니다. 예를 들어, 미국 적십자사(American Red Cross Society)가 2022년 1 월에 발표 한 데이터에 따르면 전염병이 발생한 이후 헌혈자 수가 10% 감소했습니다.

고령화는 시장 성장을 가속하는 중요한 요인입니다. 세계 인구의 고령화가 진행됨에 따라 수혈이 필요한 수술을 포함한 의료 서비스 및 정형외과 수술에 대한 수요가 증가하고 있습니다. 응고 장애, 빈혈, 외과적 수혈과 같은 만성 질환은 성인 인구 증가와 함께 계속 증가하고 있습니다. 현재 미국에서만 65세 이상 인구가 4,000만 명을 넘어섰고, 2050년까지 그 수가 두 배로 늘어날 것으로 예상되고 있습니다. 일본은 노인 인구가 가장 많은 국가로, WHO에 따르면 2050년까지 노인 인구 비율이 22.0%를 나타낼 것으로 예상되고 있어 이 시장에 잠재적인 성장 기회를 제공합니다.

또한, 자동 수혈 기기를 개발하고 안전하고 효과적인 자동 수혈 솔루션을 제공하기 위해 시장 진입 업체들의 파트너십, 합병, 제품 승인과 같은 전략적 이니셔티브의 출현은 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다. 예를 들어, 2023년 3월 Haemonetics Corporation은 Cell Saver Elite 자동 수혈 시스템용으로 설계된 최신 소프트웨어 업그레이드에 대해 미국 FDA로부터 510(k) 승인을 받았다고 발표했습니다. 이 새로운 소프트웨어는 Intelligent Control로 명명되었으며, 운영을 간소화하고 사용자 경험을 향상시키기 위한 중요한 기능 향상을 제공하며 공식적으로 시장에 출시되었습니다.

또한, 자동 수혈 시스템은 복잡한 수술 중 수술 중 출혈을 관리하고 지혈을 촉진하여 수술 결과를 개선하고 환자의 회복을 돕는 데 중요한 역할을 합니다. 2024년 1월에 발표된 Organ Procurement and Transplantation Network의 조사에 따르면, 장기 이식, 종양학, 심혈관 수술 등 고도의 외과적 개입에 대한 수요가 증가함에 따라 시장 확대에 기여하고 있습니다. 장기 이식은 총 4만 6,632건이었습니다. 이 수치에는 살아있는 기증자와 사망한 기증자의 이식이 모두 포함되어 있으며, 2023년 총 장기 이식 건수는 전년도인 2022년보다 8.7% 증가했으며, 2021년에는 전년도인 2021년에 비해 12.7% 크게 증가했으며, 2021년은 총 장기 이식 건수가 4만 건을 넘어선 첫 해였습니다. 주목할 만합니다.

자가 수혈 기기 세계 시장 세분화 보고서

이 보고서는 2018-2030년 세계, 지역 및 국가별 수익 성장을 예측하고 각 하위 부문의 최신 산업 동향 분석을 제공합니다. 이 조사에서 Grand View Research, Inc.는 세계 자가 수혈 기기 시장 보고서를 유형, 용도, 최종 용도 및 지역에 따라 세분화했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 자동 수혈 기기 시장 변수, 동향, 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 자기 수혈 장비 시장 분석 툴
  • 업계 분석 - Porter의 Five Forces 분석
  • PESTEL 분석

제4장 자기 수혈 장비 시장 : 유형별, 추정·동향 분석

• 부문 대시보드
• 자동 수혈 기기 시장 : 유형 변동 분석
• 유형별 자기 수혈 장비 시장 전망
• 시장 규모/예측 및 동향 분석(2018-2030년)
• 자기 수혈 시스템
• 소모품 및 부속품

제5장 자기 수혈 장비 시장 : 용도별, 추정·동향 분석

• 부문 대시보드
• 자기 수혈 장비 시장 : 용도 변동 분석
• 용도별 자동 수혈 기기 시장 전망
• 시장 규모/예측 및 동향 분석(2018-2030년)
• 심장혈관 외과
• 정형외과 수술
• 신경외과
• 산부인과 수술
• 기타

제6장 자동 수혈 기기 시장 : 최종 용도, 추정·동향 분석

• 부문 대시보드
• 자기 수혈 장비 시장 : 최종 용도 변동 분석
• 최종 용도별 자동 수혈 기기 시장 전망
• 시장 규모/예측 및 동향 분석(2018-2030년)
• 병원 및 클리닉
• 외래수술센터(ASC)
• 기타

제7장 자동 수혈 기기 시장 : 지역 추정·동향 분석

• 지역 대시보드
• 지역별 자동 수혈 기기 시장변수 분석
• 자기 수혈 장비 시장 : 기술과 최종 용도별 지역 추정·동향 분석
• 시장 규모/예측 및 동향 분석(2018-2030년)
• 북미
  • 북미의 자기 수혈 장비 시장 추정·예측, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
  • 유럽
  • 유럽의 자기 수혈 장비 시장 추정·예측, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양의 자기 수혈 장비 시장 추정·예측, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 라틴아메리카의 자기 수혈 장비 시장 추정·예측, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 자기 수혈 장비 시장 추정·예측, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제8장 경쟁 구도

• 시장 진출기업 분류
• 주요 기업 개요
  • Atrium Orthopedic Surgeries Corporation
  • Becton, Dickinson, and Company
  • Beijing ZKSK Technology Co. Ltd
  • Fresenius SE &Co. KGA
  • LivaNova Inc
  • Medtronic plc
  • Teleflex Incorporated
  • Haematonics Corporation
  • Braile Biomedica
  • Redax

LSH

영문 목차

영문목차

Autotransfusion Devices Market Trends

The global autotransfusion devices market size was estimated at USD 486.2 million in 2023 and is anticipated to grow at a CAGR of 6.3% from 2024 to 2030. This growth is majorly driven by the increasing number of surgical procedures attributed to the rising prevalence of lifestyle and chronic disease. According to ISAPS global survey 2023 report published in June 2024, there was a significant increase of 5.5% in surgical procedures compared to 2022. Plastic surgeons performed over 15.8 million surgical procedures globally, indicating a growing demand for aesthetic surgeries.

Furthermore, the scarcity of donated blood or allogeneic blood is also boosting the market's growth owing to the extensive use of autotransfusion systems as they are highly useful in the purification of a patient's blood. For instance , according to the data published by the American Red Cross Society in January 2022, the Red Cross has experienced a 10% decline in the number of people donating blood since the beginning of the pandemic.

The aging population is a significant factor driving the growth of the market. As the global population continues to age, there is a growing demand for healthcare services and orthopedic surgery procedures, including surgeries that require blood transfusions. Chronic diseases such as coagulopathy, anemia, and surgical blood seeking continue to increase along with the increase in the adult population. Currently, there are over 40 million people in the U.S. alone above 65 years and the number is expected to double by 2050. Japan provides potential growth opportunities to this market due to the presence of the highest geriatric population in the country. According to WHO, the percentage of the geriatric population is expected to reach 22.0% by 2050.

Additionally, the growing strategic initiatives such as partnerships, mergers, and product approvals by market players to develop autotransfusion devices and offer safe and effective auto-transfusion solutions are anticipated to boost market growth in the forecast period. For instance, in March 2023, Haemonetics Corporation announced that it had obtained 510(k) clearance from the U.S. FDA for its latest software upgrade designed for the Cell Saver Elite+ autotransfusion system. This new software, named Intelligent Control, has been officially released to the market, offering significant enhancements aimed at simplifying operations and improving user experience.

Furthermore, autotransfusion systems play a crucial role in managing intraoperative blood loss and promoting hemostasis during complex surgical procedures, thereby enhancing surgical outcomes and aiding in patient recovery. This, in turn, contributes to the expansion of the market due to the increasing demand for advanced surgical interventions including organ transplantation, oncology, and cardiovascular surgery. According to the Organ Procurement and Transplantation Network study published in January 2024, there were a total of 46,632 organ transplants performed worldwide. This number includes transplants from both living and deceased donors. The total number of organ transplants in 2023 represents an 8.7 percent increase over the previous year, 2022, and a significant 12.7 percent increase over the year before that, which was 2021. It is worth noting that 2021 was the first year in which the total number of organ transplants exceeded 40,000.

Global Autotransfusion Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global autotransfusion devices market report based on type, application, end use and region.

• Type Outlook (Revenue, USD Million, 2018 - 2030)
• Autotransfusion Systems

Intraoperative Autotransfusion Systems

Post-operative Autotransfusion Systems

Dual-mode Autotransfusion Systems

• Consumables & Accessories
• Application Outlook (Revenue, USD Million, 2018 - 2030)
• Cardiaovascular Surgeries
• Orthopedic Surgeries
• Neurological Surgeries
• Obstetrics & Gynecological Surgeries
• Others
• End use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Ambulatory Surgical Centers
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Norway

Sweden

Denmark

• Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

• Latin America

Brazil

Argentina

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Type
  • 1.1.2. Application
  • 1.1.3. End use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Autotransfusion Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Autotransfusion Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Autotransfusion Devices Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Autotransfusion Devices Market: Type Movement Analysis
• 4.3. Autotransfusion Devices Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Autotransfusion Systems
  • 4.5.1. Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Intraoperative Autotransfusion Systems
    • 4.5.2.1. Intraoperative Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Post-operative Autotransfusion Systems
    • 4.5.3.1. Post-operative Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Dual-mode Autotransfusion Systems
    • 4.5.4.1. Dual-mode Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Consumables & Accessories
  • 4.6.1. Consumables & Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Autotransfusion Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Autotransfusion Devices Market: Application Movement Analysis
• 5.3. Autotransfusion Devices Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Cardiaovascular Surgeries
  • 5.5.1. Cardiaovascular Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Orthopedic Surgeries
  • 5.6.1. Orthopedic Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Neurological Surgeries
  • 5.7.1. Neurological Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Obstetrics & Gynecological Surgeries
  • 5.8.1. Obstetrics & Gynecological Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Autotransfusion Devices Market: End use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Autotransfusion Devices Market: End use Movement Analysis
• 6.3. Autotransfusion Devices Market by End use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals and Clinics
  • 6.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Ambulatory Surgical Centres
  • 6.6.1. Ambulatory Surgical Centres Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Autotransfusion Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Autotransfusion Devices Market movement analysis
• 7.3. Autotransfusion Devices Market: Regional Estimates & Trend Analysis by Technology & End-use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Europe
  • 7.5.6. Europe Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. UK
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. UK Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Germany
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Competitive Scenario
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement scenario
    • 7.5.8.5. Germany Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. France
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Competitive Scenario
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement scenario
    • 7.5.9.5. France Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.10. Italy
    • 7.5.10.1. Key Country Dynamics
    • 7.5.10.2. Competitive Scenario
    • 7.5.10.3. Regulatory Framework
    • 7.5.10.4. Reimbursement scenario
    • 7.5.10.5. Italy Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.11. Spain
    • 7.5.11.1. Key Country Dynamics
    • 7.5.11.2. Competitive Scenario
    • 7.5.11.3. Regulatory Framework
    • 7.5.11.4. Reimbursement scenario
    • 7.5.11.5. Spain Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.12. Denmark
    • 7.5.12.1. Key Country Dynamics
    • 7.5.12.2. Competitive Scenario
    • 7.5.12.3. Regulatory Framework
    • 7.5.12.4. Reimbursement scenario
    • 7.5.12.5. Denmark Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.13. Sweden
    • 7.5.13.1. Key Country Dynamics
    • 7.5.13.2. Competitive Scenario
    • 7.5.13.3. Regulatory Framework
    • 7.5.13.4. Reimbursement scenario
    • 7.5.13.5. Sweden Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.14. Norway
    • 7.5.14.1. Key Country Dynamics
    • 7.5.14.2. Competitive Scenario
    • 7.5.14.3. Regulatory Framework
    • 7.5.14.4. Reimbursement scenario
    • 7.5.14.5. Norway Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Japan Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. China Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. India Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. South Korea Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Australia Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Thailand Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Brazil Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. Argentina Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Middle East & Africa
  • 7.8.1. Middle East & Africa Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. South Africa Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Saudi Arabia Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. UAE Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Kuwait Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Atrium Orthopedic Surgeries Corporation
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Becton, Dickinson, and Company
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Beijing ZKSK Technology Co. Ltd
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Fresenius SE & Co. KGA
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. LivaNova Inc
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Medtronic plc
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Teleflex Incorporated
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Haematonics Corporation
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Braile Biomedica
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Redax
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives

관련자료